Multi-ancestry study reveals 187 new genetic risk factors for prostate cancer

In a comprehensive multi-ancestry GWAS meta-analysis, researchers identified 451 risk variants for prostate cancer, including 187 new variants, demonstrating the utility of such studies across diverse populations. This analysis not only increased understanding of genetic risk factors but also differentiated between aggressive and non-aggressive prostate cancer types, underscoring the potential of genetic risk scoring in guiding screening and early detection strategies.

COMPASS Pathways to participate in upcoming Cantor Fitzgerald and HC Wainwright investor conferences | Psychedelic Invest

COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present

June 16, 2023

Senate panel advances PBM reform — but sidesteps anything controversial

WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to clamp down on drug middlemen, but kicked the can down

July 26, 2023

Infinity Pharmaceuticals files for bankruptcy after layoffs, scrapped merger with MEI Pharma

Infinity Pharmaceuticals filed for Chapter 11 bankruptcy in a Delaware court last Friday, a little over two months after it laid off about 78% of

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.